Supernus Pharmaceuticals to Announce Second Quarter 2026 Financial Results and Host Conference Call on August 4, 2026
Supernus Pharmaceuticals, a U.S.-based biopharmaceutical company specializing in CNS disease treatments, announced it will release its second quarter 2026 financial results after market close on August 4, 2026. The company will hold a conference call and webcast to discuss the results with investors.